- Home
- NNNN vs LIEN Comparison
NNNN vs LIEN Comparison
Compare NNNN & LIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- LIEN
- Stock Information
- Founded
- NNNN 2021
- LIEN 2021
- Country
- NNNN Germany
- LIEN United States
- Employees
- NNNN N/A
- LIEN N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LIEN
- Sector
- NNNN Health Care
- LIEN
- Exchange
- NNNN Nasdaq
- LIEN NYSE
- Market Cap
- NNNN 267.7M
- LIEN 234.6M
- IPO Year
- NNNN 2025
- LIEN 2022
- Fundamental
- Price
- NNNN $6.43
- LIEN $9.97
- Analyst Decision
- NNNN
- LIEN Hold
- Analyst Count
- NNNN 0
- LIEN 1
- Target Price
- NNNN N/A
- LIEN N/A
- AVG Volume (30 Days)
- NNNN 28.8K
- LIEN 16.8K
- Earning Date
- NNNN 01-01-0001
- LIEN 05-14-2025
- Dividend Yield
- NNNN N/A
- LIEN 13.59%
- EPS Growth
- NNNN N/A
- LIEN N/A
- EPS
- NNNN 0.06
- LIEN 0.93
- Revenue
- NNNN $8,185,146.00
- LIEN $21,665,753.00
- Revenue This Year
- NNNN N/A
- LIEN $102.44
- Revenue Next Year
- NNNN N/A
- LIEN N/A
- P/E Ratio
- NNNN $118.17
- LIEN $10.76
- Revenue Growth
- NNNN 21.95
- LIEN 81.56
- 52 Week Low
- NNNN $5.18
- LIEN $9.71
- 52 Week High
- NNNN $7.82
- LIEN $13.38
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- LIEN N/A
- Support Level
- NNNN N/A
- LIEN N/A
- Resistance Level
- NNNN N/A
- LIEN N/A
- Average True Range (ATR)
- NNNN 0.00
- LIEN 0.00
- MACD
- NNNN 0.00
- LIEN 0.00
- Stochastic Oscillator
- NNNN 0.00
- LIEN 0.00
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About LIEN CHICAGO ATLANTIC BDC INC
Chicago Atlantic BDC Inc is a specialty finance company. The company is an externally managed, closed-end, non-diversified management investment company with an investment objective to maximize risk-adjusted returns on equity for its stockholders by investing in direct loans to privately held middle-market companies, with a focus on cannabis companies.